University of California, Berkeley

Venture capital fundraising by biopharmaceutical companies has been a mixed bag so far in 2023, with a slow start to the year but a relative surge in big financings in March and April. There were only

Who: Sanofi/Scribe Therapeutics What: Sanofi is partnering with the next-generation gene editing firm founded by Jennifer Doudna, one of the inventors of CRISPR-Cas9 genome editing, to advance its

Erasca Five-Year Collaboration With MD Anderson Focused On MAPKlamp Combo Precision oncology-focused Erasca, Inc. inked a research and development collaboration on 23 August with the University of

Amylyx Hopes Sunnybrook Might Discover New Methods For Fighting ALS Although it is in the midst of a protracted effort to obtain US Food and Drug Administration approval for its investigational mitoch